Arch0 provides a platform that centralizes identity management to enhance cloud security by continuously monitoring access levels and configurations across multiple services. This approach addresses the challenge of maintaining visibility and control over user identities and permissions, ensuring real-time detection of risky behaviors without requiring changes to existing workflows.

BCHAR provides turn-key biochar production systems that convert agricultural waste into carbon‑negative biochar. The integrated hardware and MRV software automate the process from feedstock intake to carbon credit verification, ensuring transparent carbon removal. Their solutions help agribusinesses meet sustainability targets while improving soil health.

EtherealX designs and manufactures the Razor Crest Mk-1, a fully reusable medium-lift launch vehicle equipped with nine Stallion liquid rocket engines, capable of delivering up to 24.8 tonnes to low Earth orbit. This technology addresses the need for cost-effective and reliable access to space, facilitating in-space services and human spaceflight programs globally.

Keyron develops the ForePass® device, a fully endoscopic procedure that replicates the effects of metabolic surgery to reverse obesity, type 2 diabetes, and non-alcoholic steatohepatitis (NASH) without surgical intervention. This technology offers a safer and less invasive alternative to traditional gastric bypass procedures, addressing the high risks and costs associated with metabolic surgery.

Manastu Space develops a Green Propulsion System and a Debris Collision Avoidance System to enhance in-space logistics and safety. The company addresses the increasing risk of satellite collisions and debris pollution in orbit, which threatens the sustainability of the trillion-dollar space industry.

Rigor.ai develops advanced artificial intelligence solutions focused on data integrity and model validation. The platform provides automated testing frameworks to ensure machine learning pipelines deliver reliable and accurate predictions. This service helps organizations maintain high standards of performance and trustworthiness in their AI deployments.

Signatur Biosciences transforms standard qPCR machines into precision diagnostic tools by condensing complex RNA signatures into single PCR assays. This platform enables decentralized, faster, and more affordable molecular diagnostics compatible with existing hospital infrastructure. The technology allows clinicians to deliver precision insights for complex diseases, such as cancer prognosis, using widely accessible PCR equipment.

Sleepiz develops a Class IIa, CE-marked medical device that utilizes radar technology for contact-free monitoring of sleep and vital parameters, providing up to 100 times more data compared to traditional polysomnography. This solution enables continuous, objective health monitoring in the home environment, significantly reducing costs and improving compliance for patients with sleep disorders and respiratory conditions.

Surf Therapeutics develops a patented broad beam ultrasound platform designed to safely activate the body's cholinergic anti-inflammatory pathway. This non-invasive stimulation prompts the release of natural neurotransmitters to restore immune balance, shifting the body away from uncontrolled inflammation. The technology aims to provide therapeutic benefits and potentially long-lasting relief for inflammatory disorders without reliance on pharmaceuticals.

Swisspod builds AI‑powered, self‑contained hyperloop pods that travel up to 125 mph in low‑pressure vacuum tubes, eliminating the need for electrified or magnetic track infrastructure and cutting construction costs by about 90%. Their modular capsules carry two passengers or equivalent cargo, offering a zero‑emission, high‑speed alternative for intercity transport and freight that can be deployed on existing corridors or purpose‑built passive tubes.